Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04626167 · ClinicalTrials.gov registry record · Early Phase 1
Concomitant Renal and Urinary Bladder Allograft Transplantation
A Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder, sponsored by Mayo Clinic.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 30
- Enrollment target
- 2
- Study locations
NCT04626167: Recruiting Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder, sponsored by Mayo Clinic.
NCT04626167 is a Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder that is actively recruiting participants, run by Mayo Clinic. The registered enrollment target is 30 participants, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04626167, a Early Phase 1 study of Chronic Kidney Diseases and Neurogenic Bladder, is actively recruiting participants, sponsored by Mayo Clinic.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 30 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
Primary Outcome
The primary endpoint will be bladder compliance and/or the end fill pressure at bladder capacity as assessed by standardized urodynamic measures at 12 months and yearly until year 4 Urodynamic measures assessed multiple times in each subject over the follow up period will be modeled with linear mixed effects models. A discrete time relationship will estimate the mean bladder compliance or end fill pressure at 12 months and yearly until year 4. Models will adjust for baseline value, and random in
Conditions Studied
Interventions
- PROCEDURE Concomitant Renal and Urinary Bladder Allograft Transplantation
Study Locations (2)
Minnesota
- Mayo Clinic - Rochester
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-06-01 |
| Est. Completion | 2026-01 |
| Phase | Early Phase 1 |
What NCT04626167 shows while recruiting
NCT04626167 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 444-participant average among 73 other Chronic Kidney Diseases trials with a reported enrollment target (93% lower).
The record links to 9 conditions, with Chronic Kidney Diseases appearing as the primary indexed condition, and to 1 intervention - of which Concomitant Renal and Urinary Bladder Allograft Transplantation is the first listed.
NCT04626167 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04626167 about?
NCT04626167 is a clinical study titled "Concomitant Renal and Urinary Bladder Allograft Transplantation". The purpose of this study is to establish if concomitant renal and vascularized urinary bladder allograft transplantation is feasible.
What is the current status of trial NCT04626167?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 30 participants. The study started on 2021-06-01. Estimated completion is 2026-01.
What conditions does trial NCT04626167 study?
This clinical trial studies the following conditions: Chronic Kidney Diseases, Neurogenic Bladder, Transplant, Bladder Dysfunction, Bladder Outlet Obstruction.
What interventions are being tested in trial NCT04626167?
The interventions under investigation include: Concomitant Renal and Urinary Bladder Allograft Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT04626167?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04626167 being conducted?
This trial has 2 study locations across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Kidney Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04626167's enrollment target sits among peer trials
30 61st of 73 higher than 8 of 73 other Chronic Kidney Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Kidney Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Subclinical Primary Aldosteronism in Diabetes At-Risk for Kidney Disease
RECRUITING · Early Phase 1
-
Feasibility Trial of Sodium-GLucose coTransporter 2 INhibitors in Pediatric Chronic KIDney DiSease
RECRUITING · Early Phase 1
-
Safety and Tolerability of Vertebral Bone Marrow-derived Mesenchymal Stem Cells (BM-MSC) in Real World Scenarios of Patients With Chronic Kidney Disease (CKD)
RECRUITING
-
SAVE-FistulaS: the SelfWrap-Assisted ArterioVEnous Fistulas Study
RECRUITING · NA
-
Sodium Bicarbonate and Mitochondrial Energetics in Persons With CKD
RECRUITING · Phase 2
-
Anti-Inflammatory Treatment of Uremic Cardiomyopathy With Colchicine
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI